Found: 9
Select item for more details and to access through your institution.
Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells.
- Published in:
- Data (2306-5729), 2023, v. 8, n. 12, p. 177, doi. 10.3390/data8120177
- By:
- Publication type:
- Article
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.584022
- By:
- Publication type:
- Article
Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 3062, doi. 10.3390/ijms25053062
- By:
- Publication type:
- Article
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10555, doi. 10.3390/ijms241310555
- By:
- Publication type:
- Article
Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4747, doi. 10.3390/ijms24054747
- By:
- Publication type:
- Article
Ten Years of CRISPRing Cancers In Vitro.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5746, doi. 10.3390/cancers14235746
- By:
- Publication type:
- Article
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5429, doi. 10.3390/cancers14215429
- By:
- Publication type:
- Article
The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 906, doi. 10.3390/cancers13040906
- By:
- Publication type:
- Article
L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 4, p. 637, doi. 10.1002/ijc.34035
- By:
- Publication type:
- Article